ID: ALA4449729

Max Phase: Preclinical

Molecular Formula: C19H25N3O

Molecular Weight: 311.43

Molecule Type: Unknown

Representations

Canonical SMILES:  CCCCNC(=O)N1CCC(=CC#Cc2cccc(C)n2)CC1

Standard InChI:  InChI=1S/C19H25N3O/c1-3-4-13-20-19(23)22-14-11-17(12-15-22)8-6-10-18-9-5-7-16(2)21-18/h5,7-9H,3-4,11-15H2,1-2H3,(H,20,23)

Standard InChI Key:  QKWCZSGLFMPQJG-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 311.43

Molecular Weight (Monoisotopic): 311.1998

AlogP: 3.27

#Rotatable Bonds: 3

Polar Surface Area: 45.23

Molecular Species: NEUTRAL

HBA: 2

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 4.19

CX LogP: 2.71

CX LogD: 2.71

Aromatic Rings: 1

Heavy Atoms: 23

QED Weighted: 0.69

Np Likeness Score: -1.10

References

1. Graziani D, Caligari S, Callegari E, De Toma C, Longhi M, Frigerio F, Dilernia R, Menegon S, Pinzi L, Pirona L, Tazzari V, Valsecchi AE, Vistoli G, Rastelli G, Riva C..  (2019)  Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5.,  62  (3): [PMID:30624919] [10.1021/acs.jmedchem.8b01226]

Source

Source(1):

• Scientific Literature